Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Igm Biosciences Inc (IGMS)

Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 76,572
  • Shares Outstanding, K 60,293
  • Annual Sales, $ 2,680 K
  • Annual Income, $ -195,800 K
  • EBIT $ -62 M
  • EBITDA $ -60 M
  • 60-Month Beta 0.60
  • Price/Sales 29.26
  • Price/Cash Flow N/A
  • Price/Book 0.76
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.90
  • Most Recent Earnings $1.58 on 07/31/25
  • Next Earnings Date 08/13/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate -0.31
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.49
  • Prior Year -1.01
  • Growth Rate Est. (year over year) +69.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2500 +1.60%
on 08/05/25
1.3650 -6.96%
on 07/15/25
-0.0900 (-6.62%)
since 07/11/25
3-Month
1.0800 +17.59%
on 06/30/25
1.4200 -10.56%
on 05/29/25
+0.1200 (+10.43%)
since 05/13/25
52-Week
0.9200 +38.04%
on 04/09/25
22.5000 -94.36%
on 09/17/24
-7.6100 (-85.70%)
since 08/13/24

Most Recent Stories

More News
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right

IGMS : 1.2700 (-2.31%)
IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

IGMS : 1.2700 (-2.31%)
Snowflake Stock Jumps Over 21% In Premarket Following Beat-and-Raise Q3: Retail Brace For ‘Parabolic’ Run

Snowflake CEO Sridhar Ramaswamy said, “Our obsessive drive to produce product cohesion and ease of use has built Snowflake into the easiest and most cost effective enterprise data platform.”

SNOW : 228.79 (-2.55%)
IGMS : 1.2700 (-2.31%)
IWL : 171.48 (+0.21%)
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update

IGMS : 1.2700 (-2.31%)
IGM Biosciences to Present at Three Upcoming Investor Conferences

IGMS : 1.2700 (-2.31%)
Stock Index Futures Mixed Ahead of U.S. JOLTs Report and Fed Speak, Nike Earnings on Tap

December S&P 500 E-Mini futures (ESZ24) are down -0.13%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.06% this morning as investors awaited the latest reading on U.S. job openings, comments...

CVS : 75.63 (-1.46%)
AAPL : 278.78 (-0.68%)
MKC : 63.30 (-0.22%)
IGMS : 1.2700 (-2.31%)
F : 13.03 (-0.84%)
NQZ24 : 20,947.98s (-0.78%)
MU : 237.22 (+4.66%)
HPQ : 25.91 (+0.04%)
NKE : 65.86 (+0.26%)
1COV.D.DX : 59.250 (-0.05%)
PAYX : 112.06 (+0.26%)
UPS : 94.87 (+0.12%)
Change in Medivir's Board of Directors

/PRNewswire/ -- Medivir AB (Nasdaq: MVIR) and (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of...

IGMS : 1.2700 (-2.31%)
Fostrox + Lenvima continues to show promising tumor control in HCC, all patients have now dosed at least two treatment cycles

/PRNewswire/ -- Medivir AB (Nasdaq:MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high...

IGMS : 1.2700 (-2.31%)
Medivir to present at the Pareto Securities Healthcare Conference

/PRNewswire/ -- Medivir AB (Nasdaq: MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high...

IGMS : 1.2700 (-2.31%)
Medivir's Partner Tango Therapeutics received FDA clearance to start the TNG348 phase 1/2 clinical study

/PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...

IGMS : 1.2700 (-2.31%)

Business Summary

IGM Biosciences Inc. is a biotechnology company. It engages in the research and development of engineered Immunoglobulin M antibodies for the treatment of cancer patients. The company's lead product candidate is IGM-2323, a bispecific T cell engaging IgM, which are in clinical stage. IGM Biosciences...

See More

Key Turning Points

3rd Resistance Point 1.3200
2nd Resistance Point 1.3100
1st Resistance Point 1.2900
Last Price 1.2700
1st Support Level 1.2600
2nd Support Level 1.2500
3rd Support Level 1.2300

See More

52-Week High 22.5000
Fibonacci 61.8% 14.2564
Fibonacci 50% 11.7100
Fibonacci 38.2% 9.1636
Last Price 1.2700
52-Week Low 0.9200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar